An Observational Study to Gather Real-World User Feedback on DIPROBASE® Advanced Eczema Cream in Adults and Children With Eczema or Dry Skin

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-28

Study Completion Date

2024-12-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an observational study which means only data are collected from participants about their experience and symptoms, who received their usual treatment without any intervention from the study sponsor.

Atopic dermatitis, also known as eczema, is a long-lasting skin disease that causes redness, swelling, dryness, cracking, and intense itching. Xerosis is the scientific wording to describe dry skin. This condition is caused by a weakened skin barrier that does not hold moisture well.

DIPROBASE® advanced eczema cream is already available for use in the UK. It moisturizes and protects the skin.

This study is being done to understand how people use DIPROBASE® Advanced Eczema Cream and how consistently they adhere to its recommended use in their daily routines. In this study, participants will be asked to fill in an online questionnaire about their eczema symptoms and experience with DIPROBASE® Advanced Eczema Cream.

No treatment advice will be given as a part of this study.

The main purpose of this study is to gather feedback from people in the UK who have used DIPROBASE® Advanced Eczema Cream to treat their eczema or their dry skin condition. To do this, researchers will collect the following information from participants:

* intensity of eczema symptoms
* whether the cream provides a cooling or soothing effect
* whether the cream helps to ease the symptoms like itchiness, pain, or dryness

It is planned to identify and collect user data from November 2024 to January 2025. Participants will be recruited through a consumer database available with an external partner or via social media.

In this study, only data are collected. No visits or tests are required as part of this study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation)

NCT03672383

Dermatitis, Atopic

COMPLETED NA

Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis

NCT02732314

Dermatitis, Atopic Eczema

COMPLETED PHASE4

Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic Product

NCT02615561

Dermatitis, Atopic

COMPLETED NA

Efficacy Emollient on Xerosis in Children With Atopic Dermatitis

NCT01467362

Atopic Dermatitis

COMPLETED PHASE3

Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis

NCT00828412

Atopic Dermatitis

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dermatitis, Atopic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult users

Use of product 3 months prior to recruitment

MINERAL OIL + PETROLATUM (DIPROBASE® Advanced Eczema Cream, BAY987534, UI 1613882)

Intervention Type DEVICE

Product experience is assessed based on the answers provided by participants on the questions provided to them using an online questionnaire.

Caregivers of children (2-12 years old)

Use of product 3 months prior to recruitment

MINERAL OIL + PETROLATUM (DIPROBASE® Advanced Eczema Cream, BAY987534, UI 1613882)

Intervention Type DEVICE

Product experience is assessed based on the answers provided by participants on the questions provided to them using an online questionnaire.

Caregivers of children (<2 years old)

Use of product 3 months prior to recruitment

MINERAL OIL + PETROLATUM (DIPROBASE® Advanced Eczema Cream, BAY987534, UI 1613882)

Intervention Type DEVICE

Product experience is assessed based on the answers provided by participants on the questions provided to them using an online questionnaire.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MINERAL OIL + PETROLATUM (DIPROBASE® Advanced Eczema Cream, BAY987534, UI 1613882)

Product experience is assessed based on the answers provided by participants on the questions provided to them using an online questionnaire.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Participants:

* Biological sex: M/F.
* Age: \> or equal to 18 years of age.
* Mothers, fathers, grandparents, and other caregivers aged 18 years of age and above, who will report data on themselves, their children from 2 to 12 years of age or their infants under 2 years of age.
* Able to read and understand the language of the online questionnaire.
* Have used the product within the previous three (3) months.
* Agree that the data collected can be used for research, marketing and regulatory purposes.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No